These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17570908

  • 1. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A, Gombas W, Schindler SD, Peternell-Moelzer A, Eder H, Jagsch R, Fischer G.
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [Abstract] [Full Text] [Related]

  • 2. Maintenance therapy with synthetic opioids and driving aptitude.
    Schindler SD, Ortner R, Peternell A, Eder H, Opgenoorth E, Fischer G.
    Eur Addict Res; 2004; 10(2):80-7. PubMed ID: 15004452
    [Abstract] [Full Text] [Related]

  • 3. [Interactions with methadone and buprenorphine].
    Bakke E, Bachs L.
    Tidsskr Nor Laegeforen; 2009 Nov 19; 129(22):2364-6. PubMed ID: 19935937
    [Abstract] [Full Text] [Related]

  • 4. [Driving fitness/driving capacity of patients treated with methadone].
    Hauri-Bionda R, Bär W, Friedrich-Koch A.
    Schweiz Med Wochenschr; 1998 Oct 10; 128(41):1538-47. PubMed ID: 9816613
    [Abstract] [Full Text] [Related]

  • 5. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S, Kniest A, Diehl A, Mann K, Croissant B.
    Am J Drug Alcohol Abuse; 2008 Oct 10; 34(5):584-93. PubMed ID: 18720267
    [Abstract] [Full Text] [Related]

  • 6. [Buprenorphine and methadone to opiate addicts--a randomized trial].
    Kristensen Ø, Espegren O, Asland R, Jakobsen E, Lie Ø, Seiler S.
    Tidsskr Nor Laegeforen; 2005 Jan 20; 125(2):148-51. PubMed ID: 15665884
    [Abstract] [Full Text] [Related]

  • 7. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Jan 20; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jan 20; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 9. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R, Schreiber W, Zierer C.
    Psychiatr Prax; 2004 Nov 20; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [Abstract] [Full Text] [Related]

  • 10. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
    Jagsch R, Gombas W, Schindler SD, Eder H, Moody DE, Fischer G.
    Addict Biol; 2005 Dec 20; 10(4):365-71. PubMed ID: 16318959
    [Abstract] [Full Text] [Related]

  • 11. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.
    Dagtekin O, Gerbershagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R.
    Anesth Analg; 2007 Nov 20; 105(5):1442-8, table of contents. PubMed ID: 17959980
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
    Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J.
    Drug Alcohol Depend; 2007 Dec 01; 91(2-3):187-94. PubMed ID: 17624687
    [Abstract] [Full Text] [Related]

  • 13. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
    Bell J, Mutch C.
    Drug Alcohol Rev; 2006 Mar 01; 25(2):167-71. PubMed ID: 16627307
    [Abstract] [Full Text] [Related]

  • 14. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials.
    Whitham JN, Spurrier NJ, Sawyer MG, Baghurst PA, Taplin JE, White JM, Gordon AL.
    Neurotoxicol Teratol; 2010 Mar 01; 32(2):280-8. PubMed ID: 19751825
    [Abstract] [Full Text] [Related]

  • 15. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
    Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J.
    J Clin Psychopharmacol; 2006 Jun 01; 26(3):274-83. PubMed ID: 16702892
    [Abstract] [Full Text] [Related]

  • 16. Less driving impairment on buprenorphine than methadone in drug-dependent patients?
    Soyka M, Horak M, Dittert S, Kagerer S.
    J Neuropsychiatry Clin Neurosci; 2001 Jun 01; 13(4):527-8. PubMed ID: 11748323
    [No Abstract] [Full Text] [Related]

  • 17. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function.
    Shmygalev S, Damm M, Weckbecker K, Berghaus G, Petzke F, Sabatowski R.
    Drug Alcohol Depend; 2011 Sep 01; 117(2-3):190-7. PubMed ID: 21353749
    [Abstract] [Full Text] [Related]

  • 18. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
    Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H.
    J Clin Psychopharmacol; 2005 Oct 01; 25(5):490-3. PubMed ID: 16160628
    [Abstract] [Full Text] [Related]

  • 19. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.
    Addiction; 2007 Apr 01; 102(4):616-22. PubMed ID: 17286641
    [Abstract] [Full Text] [Related]

  • 20. Effect of opioid substitution therapy on alcohol metabolism.
    Clark NC, Dietze P, Lenné MG, Redman JR.
    J Subst Abuse Treat; 2006 Apr 01; 30(3):191-6. PubMed ID: 16616162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.